Table 2.
Characteristics | Treatment outcomes n (%) | |||||
---|---|---|---|---|---|---|
Cured | Treatment completed | Default | Failure | Death | Transfer-out | |
Age (years) | ||||||
≤18 | 17 (22.4) | 72 (29.8) | 0 (0) | 0 (0) | 6 (30.0) | 16 (28.6) |
19–34 | 29 (38.2) | 96 (39.7) | 6 (85.7) | 2 (100.0) | 8 (40.0) | 27 (48.2) |
35–54 | 24 (31.6) | 57 (23.6) | 1 (14.3) | 0 (0) | 4 (20.0) | 12 (21.4) |
≥55 | 6 (7.9) | 17 (7.0) | 0 (0) | 0 (0) | 2 (10.0) | 1 (1.8) |
| ||||||
Sex | ||||||
Male (=244) | 43 (17.6) | 145 (59.4) | 4 (1.6) | 1 (0.4) | 14 (5.7) | 37 (15.2) |
Female (=159) | 33 (20.7) | 97 (61.0) | 3 (1.9) | 1 (0.6) | 6 (3.8) | 19 (11.9) |
| ||||||
Sputum status (pulmonary type of TB) | ||||||
Smear-positive | 42 (42.4) | 35 (35.3) | 2 (2.0) | 0 (0) | 4 (4.0) | 16 (16.2) |
Smear-negative | 34 (11.2) | 207 (60.1) | 5 (1.6) | 2 (0.6) | 16 (5.3) | 40 (13.1) |
| ||||||
Categories of TB at start | ||||||
New | 66 (17.9) | 223 (60.6) | 6 (1.6) | 2 (0.5) | 19 (5.2) | 52 (14.1) |
Relapse | 8 (30.8) | 14 (53.8) | 0 (0) | 0 (0) | 1 (3.8) | 3 (11.5) |
Default | 1 (25.0) | 2 (50.0) | 0 (0) | 0 (0) | 0 (0) | 1 (25.0) |
Failure | 1 (20.0) | 3 (60.0) | 1 (20.0) | 0 (0) | 0 (0) | 0 (0) |
| ||||||
HIV status | ||||||
Positive (=155) | 23 (14.8) | 96 (61.9) | 1 (0.6) | 1 (0.6) | 11 (7.1) | 23 (14.8) |
Negative (=248) | 53 (21.4) | 146 (58.8) | 6 (2.4) | 1 (0.4) | 9 (3.6) | 33 (13.3) |
| ||||||
Time period between transfer-out and transfer-in (363) | ||||||
Same to 2nd day | 31 (19.3) | 91 (56.8) | 3 (1.8) | 1 (0.6) | 13 (8.1) | 21 (13.1) |
3rd day | 35 (19.2) | 110 (60.4) | 4 (2.2) | 1 (0.5) | 5 (2.7) | 27 (14.8) |
≥4th day | 5 (23.8) | 14 (66.6) | 0 (0) | 0 (0) | 1 (4.8) | 1 (4.8) |
| ||||||
Phase of TB treatment at time of transfer-out | ||||||
Intensive | 59 (21.1) | 163 (58.2) | 5 (1.9) | 1 (0.3) | 14 (5.0) | 38 (13.5) |
Continuation | 17 (13.8) | 79 (64.2) | 2 (1.6) | 1 (0.8) | 6 (4.8) | 18 (14.6) |
| ||||||
Overall | 76 (18.9%) | 242 (60.0%) | 7 (1.7%) | 2 (0.5%) | 20 (4.9%) | 56 (13.8%) |